 Credit Suisse AG lifted its position in China Biologic Products Holdings Inc NASDAQ:CBPO by 6.4 during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The fund owned 9,812 shares of the biopharmaceutical companys stock after acquiring an additional 589 shares during the period. Credit Suisse ... 